dc.contributor.author | Sonmezoglu, K. | |
dc.contributor.author | Kocael, A. | |
dc.contributor.author | Kocael, P. | |
dc.contributor.author | Halac, M. | |
dc.contributor.author | Vatankulu, Betül | |
dc.contributor.author | Şimşek, Özge | |
dc.contributor.author | Kemik, A. | |
dc.contributor.author | Ulualp, K. | |
dc.date.accessioned | 2021-03-05T18:38:29Z | |
dc.date.available | 2021-03-05T18:38:29Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | Şimşek Ö., Kocael A., Kemik A., Vatankulu B., Kocael P., Halac M., Ulualp K., Sonmezoglu K., "Decreased preoperative serum fibulin-3 levels in colon cancer patients", EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, cilt.19, ss.4076-4080, 2015 | |
dc.identifier.issn | 1128-3602 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_cb56aceb-3a65-421c-8173-cbb31d2ec267 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/134680 | |
dc.description.abstract | OBJECTIVE: Fibulin-3 is known to play a role in tumor cell malignancy, invasion and metastasis, as well as in the clinical progression of tumors. This study aimed to assess serum fibulin-3 levels in patients with colon cancer compared with healthy controls and its relationship to demographics and tumor pathology. | |
dc.language.iso | eng | |
dc.subject | Temel Bilimler | |
dc.subject | Eczacılık | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.title | Decreased preoperative serum fibulin-3 levels in colon cancer patients | |
dc.type | Makale | |
dc.relation.journal | EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES | |
dc.contributor.department | İstanbul Teknik Üniversitesi , Yabancı Diller Yüksekokulu , | |
dc.identifier.volume | 19 | |
dc.identifier.issue | 21 | |
dc.identifier.startpage | 4076 | |
dc.identifier.endpage | 4080 | |
dc.contributor.firstauthorID | 83856 | |